Recursion: Recursion Pharmaceuticals GAAP EPS of -$0.53 misses by $0.07, revenue of $4.55M misses by $14.49M

Recursion is a Utah-based biotechnology company that discovers and commercializes drugs for the treatment of genetic, inflammation and infectious diseases.